Recent treatment advances and novel therapeutic approaches in epilepsy.

F1000Prime Rep · 2015 · PMC4447056 · PMID 26097734

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Responder rates were 26% for the ganaxolone group versus 13% for placebo ( P =0.057); this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.